KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 160 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,000 | -96.8% | 171 | -96.5% | 0.00% | -100.0% |
Q1 2020 | $94,000 | +108.9% | 4,841 | +105.5% | 0.01% | +133.3% |
Q4 2019 | $45,000 | +2150.0% | 2,356 | +857.7% | 0.00% | – |
Q3 2019 | $2,000 | -99.8% | 246 | +347.3% | 0.00% | – |
Q2 2018 | $934,000 | +93300.0% | 55 | -31.2% | 0.00% | – |
Q1 2018 | $1,000 | -80.0% | 80 | -77.3% | 0.00% | – |
Q1 2017 | $5,000 | -61.5% | 352 | -74.2% | 0.00% | -100.0% |
Q4 2016 | $13,000 | – | 1,366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |